Improving outcomes of NSTEMI patients

Facilitators: R. Chaddad, D. Trabattoni

Speakers: Z. Li, Y. H. Kim, J. A. Borovac, Z. Yin

Summary

Review contemporary evidence on improving outcomes for NSTEMI patients. Topics include the effects of evolocumab on stent coverage, impact of left ventricular function with kidney disease, GRACE score-based outcomes, PCI timing, and early initiation of Tafolecimab.

Presentations available when logged in:

Effect of evolocumab on endothelial coverage of stent sruts in NSTE-ACS patients post-PCI
Impact of left ventricular ejection fraction on outcomes in NSTEMI patients with and without chronic kidney disease
Outcomes in patients with NSTEMI based on the GRACE Score and left ventricular ejection fraction
Does the PCI timing affect in-hospital mortality in over one million patients with NSTEMI in the US?
Early initiation of Tafolecimab in NSTE-ACS patients post PCI: a multicentre, open-label RCT

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Improving outcomes of NSTEMI patients

Log in or create account for free